OCGN
Price:
$0.9596
Market Cap:
$276.23M
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics In...[Read more]
Industry
Biotechnology
IPO Date
2014-12-03
Stock Exchange
NASDAQ
Ticker
OCGN
According to Ocugen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 267.40M. This represents a change of 11.67% compared to the average of 239.46M of the last 4 quarters.
The mean historical Enterprise Value of Ocugen, Inc. over the last ten years is 129.39M. The current 267.40M Enterprise Value has changed 20.57% with respect to the historical average. Over the past ten years (40 quarters), OCGN's Enterprise Value was at its highest in in the June 2021 quarter at 1.46B. The Enterprise Value was at its lowest in in the December 2014 quarter at -8900880.00.
Average
129.39M
Median
28.15M
Minimum
-39435120.00
Maximum
795.66M
Discovering the peaks and valleys of Ocugen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 15.37%
Maximum Annual Enterprise Value = 795.66M
Minimum Annual Increase = -639.29%
Minimum Annual Enterprise Value = -39435120.00
Year | Enterprise Value | Change |
---|---|---|
2023 | 107.97M | -48.04% |
2022 | 207.79M | -73.88% |
2021 | 795.66M | 332.79% |
2020 | 183.84M | 15.37% |
2019 | 1.19M | -109.87% |
2018 | -12039999.04 | -130.43% |
2017 | 39.57M | -639.29% |
2016 | -7337476.00 | -143.84% |
2015 | 16.74M | -142.44% |
2014 | -39435120.00 | -127.94% |
The current Enterprise Value of Ocugen, Inc. (OCGN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
370.47M
5-year avg
259.29M
10-year avg
129.39M
Ocugen, Inc.’s Enterprise Value is less than Vaxart, Inc. (0), greater than Novavax, Inc. (145.17M), less than CohBar, Inc. (1.00B), greater than Rain Therapeutics Inc. (-4506335.00), greater than Ocean Biomedical, Inc. (7.16M), greater than Elevation Oncology, Inc. (42.20M), greater than AVROBIO, Inc. (2.39M), greater than Zura Bio Limited (-85302404.00), greater than Enveric Biosciences, Inc. (88.66M), greater than Hepion Pharmaceuticals, Inc. (695.16K), greater than null (1.72M),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $165.33M | |
145.17M | $1.46B | |
1.00B | $1.42M | |
-4506335.00 | $44.01M | |
7.16M | $31.18M | |
42.20M | $30.92M | |
2.39M | $5.24M | |
-85302404.00 | $277.10M | |
88.66M | $4.20M | |
695.16K | $3.68M | |
1.72M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocugen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ocugen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ocugen, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ocugen, Inc. (OCGN)?
What is the 3-year average Enterprise Value for Ocugen, Inc. (OCGN)?
What is the 5-year average Enterprise Value for Ocugen, Inc. (OCGN)?
How does the current Enterprise Value for Ocugen, Inc. (OCGN) compare to its historical average?